TY - JOUR
T1 - Post-Pandemic Dynamics of the Global Circulation of Human Metapneumovirus and Respiratory Syncytial Virus
AU - Billard, Marie Noëlle
AU - Wildenbeest, Joanne G.
AU - Kole, Ruben
AU - Rodgers-Gray, Barry
AU - Fullarton, John
AU - Bont, Louis
N1 - © The Author(s) 2025. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
PY - 2025/7/15
Y1 - 2025/7/15
N2 - Background Understanding the seasonality of human metapneumovirus (hMPV) and respiratory syncytial virus (RSV) is important for public health planning. It can support rationale for using another country data to model immunization strategies where seasonality data are lacking. While some studies have investigated (sub)-national seasonality drivers, this is the first to describe global seasonality for RSV and hMPV. Methods We included 26 countries with consistent reporting and >10 detections at the peak, after searching international databases and local reports. Weekly surveillance data from January 2022 to June 2024 were included. Viral activity was defined by comparing the 4-week moving average of the positivity rate to its annual average. "Seeding"events were the first 2 consecutive weeks with a statistically significant increase in detections. Results Most countries showed seasonal patterns of RSV and hMPV, except for some tropical countries. The RSV peak occurred systematically before the hMPV peak. On a Mercator projection, hMPV appeared to circulate in a counterclockwise manner, opposite to RSV. Although global information was incomplete, the first seeding events occurred in a short time in multiple countries with year-to-year variations. Conclusions We have provided critical information on the circulation of hMPV and RSV. We only found 26 countries reporting suitable surveillance data in publicly accessible reports, which likely reflects true gaps in surveillance.
AB - Background Understanding the seasonality of human metapneumovirus (hMPV) and respiratory syncytial virus (RSV) is important for public health planning. It can support rationale for using another country data to model immunization strategies where seasonality data are lacking. While some studies have investigated (sub)-national seasonality drivers, this is the first to describe global seasonality for RSV and hMPV. Methods We included 26 countries with consistent reporting and >10 detections at the peak, after searching international databases and local reports. Weekly surveillance data from January 2022 to June 2024 were included. Viral activity was defined by comparing the 4-week moving average of the positivity rate to its annual average. "Seeding"events were the first 2 consecutive weeks with a statistically significant increase in detections. Results Most countries showed seasonal patterns of RSV and hMPV, except for some tropical countries. The RSV peak occurred systematically before the hMPV peak. On a Mercator projection, hMPV appeared to circulate in a counterclockwise manner, opposite to RSV. Although global information was incomplete, the first seeding events occurred in a short time in multiple countries with year-to-year variations. Conclusions We have provided critical information on the circulation of hMPV and RSV. We only found 26 countries reporting suitable surveillance data in publicly accessible reports, which likely reflects true gaps in surveillance.
KW - hMPV
KW - human metapneumovirus
KW - respiratory syncytial virus
KW - seasonality
KW - transmission
KW - Global Health
KW - Paramyxoviridae Infections/epidemiology
KW - Respiratory Syncytial Virus, Human/isolation & purification
KW - Humans
KW - Metapneumovirus/isolation & purification
KW - Respiratory Syncytial Virus Infections/epidemiology
KW - Disease Outbreaks
KW - Seasons
UR - https://www.scopus.com/pages/publications/105010971391
UR - https://www.mendeley.com/catalogue/1f6ae648-9689-310b-92a2-8203f5c1f183/
U2 - 10.1093/infdis/jiaf086
DO - 10.1093/infdis/jiaf086
M3 - Article
C2 - 40668101
AN - SCOPUS:105010971391
SN - 1537-6613
VL - 232
SP - S10-S18
JO - The Journal of infectious diseases
JF - The Journal of infectious diseases
IS - Supplement_1
ER -